i

iOmx Therapeutics AG

44 employees

iOmx Therapeutics focuses on the development of cancer immunotherapy treatments.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Cancer Therapy
Health Care
Pharmaceutical
Drug development
Biopharma
Immuno Oncology

Date founded

2016

Funding rounds raised

Total raised

$75M

from 8 investors over 8 rounds

i

iOmx Therapeutics AG raised $75M on October 5, 2021

Investors: M Ventures, Sofinnova Partners, Wellington Partners and MIG Capital

i

iOmx Therapeutics AG raised $45M on September 20, 2016

Investors: Wellington Partners, MPM Capital, Sofinnova Partners and M Ventures

FAQ